Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinopathy of Prematurity Both Eyes”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Post-approval studies (Phase 4)Study completedNCT03148132
What this trial is testing

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

Who this might be right for
Retinopathy of Prematurity Both EyesRetinal DiseasePremature Birth+1 more
Universidad Autonoma de San Luis Potosí 16
Post-approval studies (Phase 4)Looking for participantsNCT06520410
What this trial is testing

Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

Who this might be right for
Retinopathy of Prematurity Both EyesRetinal DiseasePersistent Fetal Vasculature+6 more
Chang Gung Memorial Hospital 60
Large-scale testing (Phase 3)UnknownNCT05033106
What this trial is testing

Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity Both Eyes
Zagazig University 36